WellPoint ties quality to payments

WellPoint (NYSE: WLP) will halt annual payment increases to about 1,500 hospitals if they fail to meet its treatment quality criteria, reports FierceHealthcare. Reimbursement increases for hospitals in 14 states that serve WellPoint's Blue Cross Blue Shield plans will be tied to a 51-indicator test. WellPoint intends to use the new, mandatory system to save the health insurer and the overall healthcare industry money, says WellPoint's Chief Medical Officer Samuel Nussbaum. He added that the system could decelerate its inpatient care spending by three to five percentage points annually over time. Article

Suggested Articles

Silicon Valley giants are building software and technology tools to serve as trusted healthcare resources in the ongoing COVID-19 outbreak.

An advisory group to ONC is standing up a coronavirus task force to tackle privacy and interoperability issues impeding frontline clinicians.

The coronavirus pandemic puts a spotlight on some of the biggest risks for states seeking to roll out Medicaid block grants, a new analysis shows.